Accès ouvert
2025
other
OpenAlex
Ian C. Henrich, Margaret M. Billingsley, Shreya Mondal, Laura Quick et autres
Cytotoxix Effects of USP6 mRNA via IFN-TRAIL
Accès ouvert
2025
other
OpenAlex
Ian C. Henrich, Margaret M. Billingsley, Shreya Mondal, Laura Quick et autres
Abstract Ewing sarcoma is an aggressive pediatric cancer that has remained refractory to current therapeutics. Immunotherapy has been unsuccessful in Ewing sarcoma, largely due to poor understanding of how its immune tumor microenvironment is regulated. We recently demonstrated that ubiquitin-specific protease 6 …
Accès ouvert
2025
other
OpenAlex
Ian C. Henrich, Margaret M. Billingsley, Shreya Mondal, Laura Quick et autres
Summary of immunostimulatory effects of USP6
Accès ouvert
2025
other
OpenAlex
Ian C. Henrich, Margaret M. Billingsley, Shreya Mondal, Laura Quick et autres
Summary of anti-tumorigenic mechanism of USP6 mRNA LNPs
Accès ouvert
2025
other
OpenAlex
Ian C. Henrich, Margaret M. Billingsley, Shreya Mondal, Laura Quick et autres
IVT USP6 mRNA recapitulates immunostimulatory effects
Accès ouvert
2025
other
OpenAlex
Ian C. Henrich, Margaret M. Billingsley, Shreya Mondal, Laura Quick et autres
Immune markers in co-cultured PBMCs
Accès ouvert
2025
other
OpenAlex
Ian C. Henrich, Margaret M. Billingsley, Shreya Mondal, Laura Quick et autres
USP6 mRNA triggers immunostimulatory effects in diverse cancer types
Accès ouvert
2025
other
OpenAlex
Ian C. Henrich, Margaret M. Billingsley, Shreya Mondal, Laura Quick et autres
Kaplan Meier of Additional Cancers
Accès ouvert
2025
other
OpenAlex
Ian C. Henrich, Margaret M. Billingsley, Shreya Mondal, Laura Quick et autres
USP6 mRNA effects in AML xenografts
Accès ouvert
2025
other
OpenAlex
Ian C. Henrich, Margaret M. Billingsley, Shreya Mondal, Laura Quick et autres
USP6 mRNA triggers immunostimulatory effects in head and neck cancer
Accès ouvert
2025
other
OpenAlex
Ian C. Henrich, Margaret M. Billingsley, Shreya Mondal, Laura Quick et autres
LNP synthesis
Accès ouvert
2025
article
OpenAlex
Carina Dehner, Jorge Torres‐Mora, Judith Jebastin Thangaiah, André M. Oliveira et autres
With the first series of PRRX1 -rearranged tumors published in 2019, the spectrum of these so-called fibroblastic tumors has been expanded. Since then, several smaller case series have been published; however, our understanding of them continues to be quite limited given their …
us, cz, pk, ca, de, dk, au, gb
(code pays fourni par la source)